Skip to main content
Top
Published in: BMC Public Health 1/2007

Open Access 01-12-2007 | Research article

Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study

Authors: Tuula Vasankari, Pekka Holmström, Jukka Ollgren, Kari Liippo, Maarit Kokki, Petri Ruutu

Published in: BMC Public Health | Issue 1/2007

Login to get access

Abstract

Background

We investigated the patient- and treatment-system dependent factors affecting treatment outcome in a two-year cohort of all treated culture-verified pulmonary tuberculosis (TB) cases to establish a basis for improving outcomes.

Methods

Medical records of all cases in 1995 – 1996 were abstracted to assess outcome of treatment. Outcome was divided into three groups: favourable, death and other unfavourable. Predictors of unfavourable outcome were assessed in univariate and multivariate analysis.

Results

Among 629 cases a favourable outcome was achieved in 441 (70.1%), 17.2% (108) died and other unfavourable outcome took place in 12.7% (80). Significant independent risk factors for death were male sex, high age, non-HIV -related immunosuppression and any other than a pulmonary specialty being responsible for stopping treatment. History of previous tuberculosis was inversely associated with the risk of death. For other unfavourable treatment outcomes, significant risk factors were pause(s) in treatment, treatment with INH+RIF+EMB/SM, and internal medicine specialty being responsible at the end of the treatment.

Conclusion

We observed a significant association with unfavourable outcome for the specialty responsible for treatment being other than pulmonary, but not for the volume of cases, which has implications for system arrangements. Poor outcomes associated with immunosuppression and advanced age, with frequent comorbidity, stress a low threshold of suspicion, availability of rapid diagnostics, and early empiric treatment as probable approaches in attempting to improve treatment outcomes in countries with very low incidence of TB.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clancy L, Rieder HL, Enarson DA, Spinaci S: Tuberculosis elimination in the countries of Europe and other industrialized countries. Eur Respir J. 1991, 4: 1288-1295.PubMed Clancy L, Rieder HL, Enarson DA, Spinaci S: Tuberculosis elimination in the countries of Europe and other industrialized countries. Eur Respir J. 1991, 4: 1288-1295.PubMed
2.
go back to reference World Health Organization: WHO Tuberculosis Programme: framework for effective tuberculosis control. World Health Organization Document WHO/TB/94.179. 1994, World Health Organization, Geneva World Health Organization: WHO Tuberculosis Programme: framework for effective tuberculosis control. World Health Organization Document WHO/TB/94.179. 1994, World Health Organization, Geneva
3.
go back to reference Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, Raviglione MC, World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group: European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002, 19 (4): 765-775. 10.1183/09031936.02.00261402.CrossRefPubMed Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, Raviglione MC, World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group: European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002, 19 (4): 765-775. 10.1183/09031936.02.00261402.CrossRefPubMed
4.
go back to reference Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, Zalesky R: Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working group of the World Health organisation (WHO) and the European Region of the International Union against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J. 1998, 12: 505-510. 10.1183/09031936.98.12020505.CrossRefPubMed Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, Zalesky R: Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working group of the World Health organisation (WHO) and the European Region of the International Union against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J. 1998, 12: 505-510. 10.1183/09031936.98.12020505.CrossRefPubMed
5.
go back to reference WHO, IUATLD, and KNCV: Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001, 5 (3): 213-215. WHO, IUATLD, and KNCV: Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001, 5 (3): 213-215.
6.
go back to reference EuroTB: Classification of treatment outcomes. WHO Euro/EuroTB joint data collection – CISID. 2001 EuroTB: Classification of treatment outcomes. WHO Euro/EuroTB joint data collection – CISID. 2001
7.
go back to reference Zellweger JP, Coulon P: Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis. 1998, 2 (5): 372-377.PubMed Zellweger JP, Coulon P: Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis. 1998, 2 (5): 372-377.PubMed
8.
go back to reference Wobeser W, Yuan L, Naus M, the Tuberculosis Treatment Completion Study Group: Outcome of pulmonary tuberculosis treatment in the tertiary care setting -Toronto 1992/93. 1999, CMAJ: Canadian Medical Association Journal, 160 (6): 789-794. Wobeser W, Yuan L, Naus M, the Tuberculosis Treatment Completion Study Group: Outcome of pulmonary tuberculosis treatment in the tertiary care setting -Toronto 1992/93. 1999, CMAJ: Canadian Medical Association Journal, 160 (6): 789-794.
9.
go back to reference Chin DP, Cummings KC, Sciortino S, Snyder DC, Johnson LF, Westenhouse JL, Royce SE: Progress and problems in achieving the United States national target for completion of antituberculosis treatment. Int J Tuberc Lung Dis. 2000, 4 (8): 744-751.PubMed Chin DP, Cummings KC, Sciortino S, Snyder DC, Johnson LF, Westenhouse JL, Royce SE: Progress and problems in achieving the United States national target for completion of antituberculosis treatment. Int J Tuberc Lung Dis. 2000, 4 (8): 744-751.PubMed
10.
go back to reference Centis R, Ianni A, Migliori GB: Evaluation of tuberculosis treatment results in Italy, report 1998. Tuberculosis section of the National AIPO Study Group on Infectious Disease and the SMIRA Group. Monaldi Arch Chest Dis. 2000, 55 (4): 293-298.PubMed Centis R, Ianni A, Migliori GB: Evaluation of tuberculosis treatment results in Italy, report 1998. Tuberculosis section of the National AIPO Study Group on Infectious Disease and the SMIRA Group. Monaldi Arch Chest Dis. 2000, 55 (4): 293-298.PubMed
11.
go back to reference Ormerod LP, Horsfield N, Green RM: Tuberculosis treatment outcome monitoring: Blackburn 1988–2000. Int J Tuberc Lung Dis. 2002, 6 (8): 662-665.PubMed Ormerod LP, Horsfield N, Green RM: Tuberculosis treatment outcome monitoring: Blackburn 1988–2000. Int J Tuberc Lung Dis. 2002, 6 (8): 662-665.PubMed
12.
go back to reference Cayla JA, Caminero JA, Rey R, Lara N, Valles X, Galdos-Tanguis H, Working Group on Completion of Tuberculosis Treatment in Spain: Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Di. 2004, 8 (4): 458-464. Cayla JA, Caminero JA, Rey R, Lara N, Valles X, Galdos-Tanguis H, Working Group on Completion of Tuberculosis Treatment in Spain: Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Di. 2004, 8 (4): 458-464.
13.
go back to reference EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region: Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2004. Institut de veille sanitaire, Saint-Maurice, France. 2006 EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region: Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2004. Institut de veille sanitaire, Saint-Maurice, France. 2006
14.
go back to reference Lillebaek T, Poulsen S, Kok-Jensen A: Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. Int J Tuberc Lung Dis. 1999, 3 (7): 603-612.PubMed Lillebaek T, Poulsen S, Kok-Jensen A: Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. Int J Tuberc Lung Dis. 1999, 3 (7): 603-612.PubMed
15.
go back to reference Trnka L, Daòkova D, Krejbich F: Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country?. Int J Tuberc Lung Dis. 2001, 5 (3): 250-256.PubMed Trnka L, Daòkova D, Krejbich F: Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country?. Int J Tuberc Lung Dis. 2001, 5 (3): 250-256.PubMed
16.
go back to reference Helbling P, Medinger C, Altpeter E, Raeber PA, Beeli D, Zellweger JP: Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly. 2002, 132 (35–36): 517-522.PubMed Helbling P, Medinger C, Altpeter E, Raeber PA, Beeli D, Zellweger JP: Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly. 2002, 132 (35–36): 517-522.PubMed
17.
go back to reference Ormerod LP, Prescott RJ: The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. Clin Med. 2003, 3 (1): 57-61.CrossRef Ormerod LP, Prescott RJ: The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. Clin Med. 2003, 3 (1): 57-61.CrossRef
18.
go back to reference Faustini A, Hall AJ, Perucci CA: Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J. 2005, 26: 503-510. 10.1183/09031936.05.00103504.CrossRefPubMed Faustini A, Hall AJ, Perucci CA: Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J. 2005, 26: 503-510. 10.1183/09031936.05.00103504.CrossRefPubMed
19.
go back to reference Grzybowski S, Enarson DA: The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc. 1978, 53: 70-75.PubMed Grzybowski S, Enarson DA: The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc. 1978, 53: 70-75.PubMed
20.
go back to reference Vasankari T, Kokki M, Holmström P, Liippo K, Sarna S, Ruutu P: Great diversity of tuberculosis treatment in Finland. Euro Surveill. 2007, 12 (1): [Epub ahead of print]: PMID: 17370977 Vasankari T, Kokki M, Holmström P, Liippo K, Sarna S, Ruutu P: Great diversity of tuberculosis treatment in Finland. Euro Surveill. 2007, 12 (1): [Epub ahead of print]: PMID: 17370977
21.
go back to reference Farah M, Tverdall A, Steen T, Heldall E, Brantsaeter A, Bjune G: Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health. 2005, 5: 14-10.1186/1471-2458-5-14.CrossRefPubMedPubMedCentral Farah M, Tverdall A, Steen T, Heldall E, Brantsaeter A, Bjune G: Treatment outcome of new culture positive pulmonary tuberculosis in Norway. BMC Public Health. 2005, 5: 14-10.1186/1471-2458-5-14.CrossRefPubMedPubMedCentral
22.
go back to reference Falzon D, Le Strat Y, Belghiti F, Infuso A, EuroTB Correspondents: Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis. 2005, 9: 1224-1229.PubMed Falzon D, Le Strat Y, Belghiti F, Infuso A, EuroTB Correspondents: Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis. 2005, 9: 1224-1229.PubMed
23.
go back to reference The Finnish Leukaemia Group: Interhospital differences in the treatment of acute leukaemia in adults. Scand J Haematol. 1979, 23: 119-123. The Finnish Leukaemia Group: Interhospital differences in the treatment of acute leukaemia in adults. Scand J Haematol. 1979, 23: 119-123.
24.
go back to reference Halm EA, Lee C, Chassin MR: Is volume related to outcome in health care? A systematic review and methodological critique of the literature. Ann Intern Med. 2002, 137: 511-520.CrossRefPubMed Halm EA, Lee C, Chassin MR: Is volume related to outcome in health care? A systematic review and methodological critique of the literature. Ann Intern Med. 2002, 137: 511-520.CrossRefPubMed
25.
go back to reference Thiemann DR, Coresh J, Oetgen WJ, Powe NR: The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999, 340: 1640-1648. 10.1056/NEJM199905273402106.CrossRefPubMed Thiemann DR, Coresh J, Oetgen WJ, Powe NR: The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999, 340: 1640-1648. 10.1056/NEJM199905273402106.CrossRefPubMed
26.
go back to reference Kokki M, Holmström P, Ruutu P: High sensivity for tuberculosis in a laboratory-based national integrated infectious disease surveillance system in Finland. Euro Surveill. 2005, 10: 90-93.PubMed Kokki M, Holmström P, Ruutu P: High sensivity for tuberculosis in a laboratory-based national integrated infectious disease surveillance system in Finland. Euro Surveill. 2005, 10: 90-93.PubMed
27.
go back to reference Lääkintöhallitus: Tuberkuloosi ja sen lääkehoito. Finnish National Board of Health. Tuberculosis and its treatment. Kapseli 15. Lääkintöhallituksen julkaisu 1985. (in Finnish) Lääkintöhallitus: Tuberkuloosi ja sen lääkehoito. Finnish National Board of Health. Tuberculosis and its treatment. Kapseli 15. Lääkintöhallituksen julkaisu 1985. (in Finnish)
28.
go back to reference World Health Organization Tuberculosis Unit, Division of Communicable Disease: Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Programmes. WHO/TB/91, 161 World Health Organization Tuberculosis Unit, Division of Communicable Disease: Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Programmes. WHO/TB/91, 161
29.
go back to reference American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Resp Dis. 1986, 134: 355-363. American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Resp Dis. 1986, 134: 355-363.
30.
go back to reference Joint Tuberculosis Committee of the British Thoracic Society: Chemotherapy and management of tuberculosis in the United Kingdom: recommendations. Thorax. 1990, 45: 403-408.CrossRef Joint Tuberculosis Committee of the British Thoracic Society: Chemotherapy and management of tuberculosis in the United Kingdom: recommendations. Thorax. 1990, 45: 403-408.CrossRef
31.
go back to reference Davies PDO: Clinical tuberculosis. London, MacMillan Education. 1994 Davies PDO: Clinical tuberculosis. London, MacMillan Education. 1994
32.
go back to reference Tala E: Tuberkuloosin lääkehoito ja -profylaksia. Tuberculosis treatment and prophylaxis. Duodecim. 1993, 109: 69-75. (in Finnish)PubMed Tala E: Tuberkuloosin lääkehoito ja -profylaksia. Tuberculosis treatment and prophylaxis. Duodecim. 1993, 109: 69-75. (in Finnish)PubMed
33.
go back to reference Vasankari T: Analysis of tuberculosis deaths in Finland from 1974 to 1993. Thesis. Turku University Series D. 1998, 304- Vasankari T: Analysis of tuberculosis deaths in Finland from 1974 to 1993. Thesis. Turku University Series D. 1998, 304-
34.
go back to reference de Meer G, van Geuns HA: Rising case fatality of bacteriologically proven pulmonary tuberculosis in the Netherlands. Tuberc Lung Dis. 1992, 73: 83-86. 10.1016/0962-8479(92)90060-W.CrossRef de Meer G, van Geuns HA: Rising case fatality of bacteriologically proven pulmonary tuberculosis in the Netherlands. Tuberc Lung Dis. 1992, 73: 83-86. 10.1016/0962-8479(92)90060-W.CrossRef
35.
go back to reference Story A, Murad S, Verheyen M, Roberts W, Hayward AC: Tuberculosis in London -the importance of homelessness, problem drug use and prison. Thorax. 2007, 62 (8): 667-71. 10.1136/thx.2006.065409.CrossRefPubMedPubMedCentral Story A, Murad S, Verheyen M, Roberts W, Hayward AC: Tuberculosis in London -the importance of homelessness, problem drug use and prison. Thorax. 2007, 62 (8): 667-71. 10.1136/thx.2006.065409.CrossRefPubMedPubMedCentral
Metadata
Title
Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study
Authors
Tuula Vasankari
Pekka Holmström
Jukka Ollgren
Kari Liippo
Maarit Kokki
Petri Ruutu
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2007
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-7-291

Other articles of this Issue 1/2007

BMC Public Health 1/2007 Go to the issue